-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- UNITED THERAPEUTICS Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $35.4M, a 62.4% increase year-over-year.
- UNITED THERAPEUTICS Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $138M, a 349% increase year-over-year.
- UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2023 was $89.4M.
- UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2022 was -$29.1M, a 177% decline from 2021.
- UNITED THERAPEUTICS Corp annual Nonoperating Income (Expense) for 2021 was $38M, a 16.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)